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gesting that glomerular hypertension might be involved in thePressure-induced expression of monocyte chemoattractant
progression of renal diseases through the expression of MCP-1protein-1 through activation of MAP kinase.
in MC.Background. In glomerular hypertension, mesangial cells
(MC) are subjected to at least two physical forces: a high
pressure and mechanical stretch. In 5/6 nephrectomized rat,
a model of progressive glomerular sclerosis associated with
Glomerular capillary hypertension is an importantglomerular hypertension, monocyte chemoattractant protein-1
causative factor of glomerular sclerosis [1, 2]. Since the(MCP-1) is expressed in glomeruli, suggesting the possible role
of MCP-1 in the pathogenesis of glomerular sclerosis; however, mesangial area occupies a central location and is sur-
whether pressure directly affects MCP-1 expression remains rounded by glomerular capillaries, increased glomerular
undetermined. Here we examined the effects of pressure on pressure results in at least two major effects: a highMCP-1 expression in cultured rat MC and the signal transduc-
pressure and stretch on mesangial cells (MC) [3, 4]. Usingtion pathways that lead to MCP-1 expression.
Methods. Pressure was applied to MC by instilling com- the pressure apparatus and helium gas [5], as modified
pressed helium gas into sealed plates. MCP-1 mRNA and pro- by our laboratory [6], we have previously reported that
tein levels in MC were detected by reverse transcription-poly- increased pressure induces overexpression of platelet-
merase chain reaction (RT-PCR) or Northern blotting and
derived growth factor-B (PDGF-B) mRNA in MC andELISA or Western blotting, respectively. Mitogen-activated
that pressure-induced MC proliferation is inhibited byprotein (MAP) kinase activity was measured with the catalytic
activity of p42/p44 MAP kinase and anti-phospho p42/p44 neutralizing antibodies against PDGF [6]. These results
MAP kinase antibody. A transient transfection assay that spe- suggest that PDGF-B plays an important role in the
cifically modulates MAP kinase kinase (MEK) activity was pressure-induced MC proliferation. Similar results havecarried out.
been reported following exposure of MC to stretchingResults. MCs subjected to external pressure expressed
forces (abstract; Kaname et al, J Am Soc Nephrol 8:402A,MCP-1 mRNA rapidly and transiently with the peak level
noted at 10 minutes and 80 mm Hg pressure. MCP-1 protein 1997), suggesting the involvement of PDGF in the
levels in cell lysates and culture medium also significantly in- pathogenesis of glomerular sclerosis induced by physical
creased after pressure loading. Pressure rapidly increased the
forces, as seen in glomerular hypertension [7].phosphorylation level and activity of p42/p44 MAP kinase.
In the 5/6 nephrectomized rat, a model of progressiveTreatment of MC with a MAP kinase kinase (MEK) inhibitor,
PD98059, suppressed levels of both pressure-induced MAP glomerular sclerosis associated with glomerular hyper-
kinase activities and MCP-1 mRNA expression. The constitu- tension, infiltration of monocytes/macrophages into the
tively activated type of MEK1 induced MCP-1 expression glomeruli has been reported to occur following MC pro-(13.7-fold) even in non-pressurized MC.
liferation and PDGF expression in glomeruli, leading toConclusions. Our results indicate that pressure per se can
progression of glomerular sclerosis [7–9]. These findingsinduce MCP-1 via activation of MAP kinase pathway, sug-
suggest that the influx of monocytes/macrophages in glo-
meruli may participate in the development of glomerular
Key words: mesangial cells, glomerular hypertension, transfection
sclerotic changes induced by elevated glomerular pres-assay, progressive glomerulosclerosis, mitogen-activated protein, MAP
kinase kinase. sure [7, 9]. Schlondorff et al have reported that various
chemokines exhibit strong chemoattractant activities for
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attractant protein-1 (MCP-1), a member of the C-C cin at 37C in 5% CO2 incubator. To set the cells in a
group, is a potent chemokine for monocytes/macro- quiescent stage, MC were maintained in DMEM con-
phages and plays an active role in renal injury [9]. MCP-1 taining 0.5% fetal calf serum for 48 hours. Cells were
is expressed in a variety of renal cell types, including used between 5 and 13 passages.
MC in human and experimental glomerulonephritis [9–
Pressure loading apparatus13]. Using immunohistochemistry, Schiller and Moran
showed increased glomerular MCP-1 expression in 5/6 We used the pressure loading apparatus described pre-
nephrectomized rats prior to the infiltration of mono- viously by our laboratory (Miwa Co., Tokyo, Japan) [6].
cytes/macrophages into glomeruli [14]. They also demon- The apparatus consisted of a resealable steel chamber
strated that a low protein diet reduced both the MCP-1 with inlet and outlet ports. The inlet port was connected
expression and infiltration of monocytes/macrophages, through a tube to a reservoir of compressed helium,
suggesting that elevated glomerular pressure directly af- while the exit port was connected through a tube to a
fects MCP-1 expression on glomerular cells, especially sphygmomanometer and air-release valve. Compressed
in MC. To our knowledge, however, no studies have helium gas was pumped into the chamber to raise inter-
previously examined the effects of pressure per se on nal chamber pressure. During the delivery of helium gas
MCP-1 expression in MC. into the apparatus, no prepacked room air was released
Mitogen-activated protein (MAP) kinase is an impor- so that the partial pressures of the gases originally pres-
tant mediator of growth-mediated signal transduction in ent in the chamber, such as O2, N2, and CO2, were kept
a variety of cells, including MC [15–19]. Several signaling constant [29], consistent with the Boyle-Charle law, as
pathways such as p42/p44 MAP kinase are involved in described previously [5]. The plates used for our experi-
the regulation of MCP-1 expression [20–25]. We and ments were placed on a warm plate (37C) inside the
others have shown that pressure is a potent activator of chamber. The partial pressure of O2, temperature, and
p42/p44 MAP kinase as well as protein kinase C (PKC) pH of the incubation medium in the plates remained
and tyrosine kinase in MC [6, 26], suggesting the possible constant throughout the experiments.
role of p42/p44 MAP kinase in the pressure-induced
MCP-1 expression. In the present study, we examined Semiquantitative reverse transcription-polymerase
whether externally applied pressure alone induces MCP-1 chain reaction (RT-PCR) and Northern blotting
expression in cultured rat MC. We also studied whether
Total RNA was extracted by using an RNeasy kit
p42/p44 MAP kinase is involved in these pressure-
(Qiagen, Hilden, Germany). The first-strand cDNA was
induced events.
synthesized from 1 g of total RNA in 50 mmol/L Tris-
HCl buffer (pH 8.3) containing 200 ng random hexamers,
METHODS 3 mmol/L MgCl2, 400 U murine Moloney leukemia virus
reverse-transcriptase, 500 mol/L dNTP, 15 mmol/LMaterials
dithiothreitol (DTT), and 75 mmol/L KCl in a final vol-Platelet-derived growth factor-B was obtained from
ume of 7.5 L (1 hour at 37C) as described previouslySigma (St. Louis, MO, USA). PD98059, calphostin C,
[28]. Each sample was assayed for MCP-1 and glyceralde-and wortmannin were from Calbiochem (San Diego, CA,
hyde-3-phosphate dehydrogenase (GAPDH) cDNA inUSA). The p42/p44 MAP kinase enzyme assay system
separate tubes using specific primers for PCR; MCP-1;and [-32P] ATP (37 MBeq/mmol) were from Amersham
sense; 5-TATGCAGGTCTCTGTCACGC-3, antisense;Life Science (Arlington Heights, IL, USA). Monoclonal
5-AAGTGTTGAACCAGGATTCACA-3, GAPDH;anti-phospho-p44/p42 MAP kinase and polyclonal anti-
sense; 5-TCCCTCAAGATTGTCAGCAA-3, antisense;p44/p42 MAP kinase antibodies were purchased from
5-AGATCCACAACGGATACATT-3. PCR was per-New England Biolabs (Beverly, MA, USA). Monoclonal
formed by incubating 1 g of the sample cDNA with 68anti-hemagglutinin (HA) antibody (12CA5) was ob-
mmol/L KCl, 45 mmol/L Tris-HCl (pH 8.3), 15 mmol/Ltained from Boehringer Mannheim (Indianapolis, IN,
DTT, 9 mmol/L MgCl2, 80 g/mL bovine serum albuminUSA). Polyclonal anti-rat MCP-1 antibody was from
(BSA), 2.5 U Taq DNA polymerase, 1.8 mmol/L dNTP,Santa Cruz Biotechnology (Santa Cruz, CA, USA).
and 40 pmol of each primer in a final volume of 25 L.
Mesangial cell cultures PCR was carried out under the following conditions; 1
minutes at 94C, 45 seconds at 60C, and 45 seconds atRat glomerular MC were isolated from glomeruli har-
72C. For MCP-1 and GAPDH, 30 and 25 cycles werevested from four-week-old Wistar rats by the differential
used, respectively. Primer sets for MCP-1 and GAPDHsieving method and were characterized as previously de-
generated 595 and 308 bp products, respectively. Thescribed [27, 28]. MC were grown in Dulbecco’s modified
samples were then subjected to agarose gel electrophore-Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum, 200 g/mL penicillin, 100 g/mL streptomy- sis and stained with ethidium bromide to visualize DNA
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bands, followed by scanning densitometry (FB1200S; phoretically transferred to nitrocellulose membrane (No-
vex, San Diego, CA, USA) for 90 minutes at 150 mA.Canon, Tokyo).
Standard Northern blotting was performed as de- The filters were incubated with blocking buffer (5% non-
fat dry milk; alternatively, 5% BSA for anti-p44/p42scribed [30]. cDNA probe for GAPDH was purchased
from Clontech (Palo Alto, CA, USA). Rat MCP-1 cDNA MAP kinase antibody), in T-TBS (50 mmol/L Tris, 150
mmol/L NaCl, and 0.5% Tween 20, pH 7.4) for onewas constructed using the PCR as described previously
in this article. The PCR product was subcloned into hour and then incubated overnight in a cold room with
either MCP-1 (1:2000), anti-phospho-p44/p42 MAP ki-pCRII-TOPO (Invitrogen, Groningen, The Netherlands),
and the sequence was confirmed. RNA samples were nase (1:1000), anti-p44/p42 MAP kinase (1:2000), or
12CA5 (1:400) antibodies. Blots were visualized by thesubjected to 1% formaldehyde-agarose gels, transferred
onto nylon membranes, and covalently cross-linked to enhanced chemiluminescence (ECL) reaction (Amer-
sham Life Science).the membrane with ultraviolet light. The membranes
were hybridized with a cDNA probe for MCP-1 labeled
p42/p44 MAP kinase assaywith [32P]dCTP by using Rediprime II (Amersham Phar-
macia Biotech, Buckinghamshire, UK) and then rehy- The activity of p42/p44 MAP kinase was assayed using
a synthetic peptide (KRELVEPLTPAGEAPNQALLR;bridized with a probe for GAPDH. The membranes were
subsequently exposed to Hyperfilm-MP (Amersham Phar- Amersham Life Science) as a specific MAP kinase sub-
strate, based on the assay protocol recommended bymacia Biotech) with an intensifying screen at 70C.
the manufacturer. After exposure of serum-starved MC
ELISA for MCP-1 grown on a six-well plate to 80 mm Hg pressure, MC
were lysed with ice-cold lysis buffer (10 mmol/L Tris-Monocyte chemoattractant protein-1 concentrations
in the culture supernatants of MC were measured by HCl, pH 7.4, 20 mmol/L NaCl, 2 mmol/L EGTA, 2
mmol/L DTT, 1 mmol/L orthovanadate, 1 mmol/L phe-using an enzyme-linked immunosorbent assay (ELISA)
kit (Cosmo Bio, Tokyo, Japan) following the method nylmethylsulfonylfluoride, 10 g/mL leupeptin, and 10
g/mL aprotinin) and centrifuged at 14,000  g for 15recommended by the manufacturer. Briefly, cells were
exposed to 80 mm Hg pressure for 10 minutes and incu- minutes at 4C. The supernatants (1 g protein) were
incubated with 1.2 mmol/L [-32P] ATP (1 Ci) and 2bated for up to 24 hours. Culture supernatants (50 L)
were added into flat-bottomed 96-well ELISA plates mmol/L substrate peptide in 75 mmol/L HEPES buffer,
pH 7.4, containing 1.2 mmol/L MgCl2 for 30 minutes atcoated with goat anti-rat MCP-1 serum together with
biotinylated anti-MCP-1 solution and incubated for 30 30C. The resultant solution was applied to a phosphocel-
lulose membrane (Amersham), followed by extensiveminutes at room temperature. Stabilized chromogen
(100 L) was added to each well and incubated for addi- washing in 1% acetic acid and then in H2O. The radioac-
tivity trapped on the membrane was measured in a liquidtional 30 minutes. After adding stop solution (100 L),
the absorbance at 450 nm was analyzed by using a plate scintillation Coulter counter (LS7000; Beckman, Fuller-
ton, CA, USA).reader (model 450; BioRad, Hercules, CA, USA). The
minimum sensitivity of ELISA for MCP-1 was 8.0 pg/mL.
Plasmids and transfections
Western blotting Three plasmids containing pMCLHA-tagged MEK1
(wild-type and constitutively activated type) were kindlyWestern blotting was performed as described pre-
viously [31]. Briefly, MC grown to subconfluence were provided by Dr. N.G. Ahn (Department of Chemistry
and Biochemistry, University of Colorado, Boulder, CO,serum starved for 48 hours. After exposure of cells to
pressure, they were lysed with RIPA lysis buffer [150 USA) [32]. Puromycin-resistant plasmid pHA262pur
was obtained from Dr. Heinte Riele (Division of Molecu-mmol/L NaCl, 50 mmol/L Tris-HCl, pH 7.5, 1% Triton
X-100, 1% deoxycholate, 0.1% SDS, and 2 mmol/L lar Carcinogenesis, The Netherlands Cancer Institute),
[33]. Either wild-type or constitutively activated HA-ethylenediaminetetraacetic acid (EDTA)] containing 2
mmol/L phenylmethylsulfonyl fluoride, 10g/mL aproti- MEK1 (8 g) was transfected into MC using the cationic
liposome (lipofectamine; GIBCO BRL, Gaithersburg,nin, 10 g/mL leupeptin, 50 g/mL soybean trypsin in-
hibitor, 20 mmol/L iodoacetamide, 50 mmol/L sodium MD, USA)-mediated transfection method together with
pHA262pur (1 g) [28, 34]. To increase the expression offluoride, and 1 mmol/L sodium orthovanadate. The ly-
sates were clarified by centrifugation at 14,000 g for 15 transfected genes, 5 mmol/L sodium butyrate was added
to the culture medium. Cells expressing HA-MEK1 wereminutes at 4C. Protein concentrations were determined
spectrophotometrically using protein concentration re- selected as described previously [34]. Briefly, at 24 hours
after transfection, cells were maintained for two daysagent (BioRad), and samples were adjusted to equal
protein concentrations and volumes. Samples were re- in culture media containing 1 g/mL puromycin, and
cultured for an additional 24 hours in the regular culturesolved onto 12 to 15% polyacrylamide gels and electro-
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First, the dynamics of the pressure effects on the ex-
pression of MCP-1 mRNA were examined in cultured
MC. We have previously shown that the maximal in-
crease in DNA synthesis and cell proliferation occurred
at a pressure level of 80 mm Hg [6]. Application of a
similar pressure to MC caused a rapid increase in the
expression of MCP-1 mRNA at 5 minutes with a peak
noted at 10 minutes but decreased thereafter to the basal
level at 30 minutes by RT-PCR (Fig. 2 A, B). Similar
increased mRNA expression of MCP-1 was also ob-
served by using Northern blot analysis (Fig. 2C). In con-
trast, MCP-1 mRNA levels in control cells (not subjected
to pressure) did not change throughout the experiment
(data not shown). Since it has been reported that MC
produce MCP-1 in response to various cytokines such
as PDGF-B [25], we used PDGF-B as a positive control.
Treatment of MC with PDGF-B (25 ng/mL) for 10 min-
utes significantly increased MCP-1 expression up to 4.6
1.7-fold, which was twofold higher than that of 80 mm Hg
pressure stimulation (Fig. 3).
Using Western blotting and ELISA, we examined
MCP-1 protein in cell lysates and culture supernatantsFig. 1. Semiquantitative reverse transcription-polymerase chain reac-
produced by MC after application of the pressure stimu-tion (RT-PCR) for monocyte chemoattractant protein-1 (MCP-1). To-
tal RNAs extracted from cultured rat mesangial cells were examined lus (80 mm Hg) for 10 minutes. MCP-1 protein levels in
for the expression of MCP-1 by RT-PCR to confirm the accuracy of MC increased significantly at one hour after pressuremRNA quantity amplified by PCR. PCR was performed by differential
loading, and the levels remained unchanged up to 12PCR cycles (A, 1 g of tRNA per lane) or incubating serially lower
amounts of mesangial RNA (B, 1:1 g of tRNA, 30 cycles). hours (Fig. 4A). In addition, the mean concentration of
MCP-1 protein in the culture supernatants after 12 hours
with ELISA was significantly higher (163.3  27.8%)
than in the control (without pressure; P  0.05, N 	 3:media containing 0.5% serum without puromycin. Equal
Fig. 4B). In contrast, basal MCP-1 production by MCexpression of each HA-MEK1 plasmid was confirmed
remained unchanged throughout the experiments. Weby Western blotting using anti-HA antibody 12CA5
also examined the effect of different pressure levels on(Fig. 8B).
MCP-1 mRNA expression. Expression of MCP-1 mRNA
Statistical analysis significantly increased when the chamber pressure was
increased for 10 minutes. However, only pressures moreData are expressed as mean  SD. Differences be-
than 60 mm Hg influenced the expression of MCP-1tween groups were examined for statistical significance
mRNA, with a maximal induction noted at 80 mm Hgusing the Student t test. A P value less than 0.05 denoted
(Fig. 5). Interestingly, MCP-1 mRNA level at 100 mm Hgthe presence of a statistically significant difference.
was less than that at 80 mm Hg, suggesting that the
physical pressure for maximal induction of MCP-1 is 80
RESULTS mm Hg. Based on the results shown in Figures 2 and 5,
Pressure-induced MCP-1 mRNA expression and a pressure stimulus of 80 mm Hg applied for 10 minutes
MCP-1 protein secretion by MC was selected in the remaining experiments described
later in this article.To confirm the accuracy of the mRNA quantity ampli-
fied by RT-PCR, PCR for MCP-1 was performed by
Role of MAP kinase and PKC on pressure-dependentdifferential PCR cycles (Fig. 1A) or by incubating serially
overexpression of MCP-1 mRNAlower amounts of mesangial RNA (Fig. 1B), which re-
The next series of experiments investigated the intra-vealed a dose- and cycle-dependent increase in the PCR
cellular signaling pathways involved in pressure-inducedproduct. We therefore amplified 1 g of each RNA by
MCP-1 expression. Because external pressure applica-30 cycles in the following experiments. Similarly, PCR
tion is known to activate MAP kinase and/or PKC, lead-for GAPDH was performed using 21 to 27 cycles or by
ing to MC proliferation [6, 35], MC were treated withincubating serially lower amounts of RNA (data not
inhibitors of p42/p44 MAP kinase kinase (MEK; 25shown). Accordingly, 1 g of RNA and 25 cycles were
selected for amplification of GAPDH. mol/L PD98059), PKC (1 mol/L calphostin C), or a
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Fig. 3. Effects of PDGF-BB on MCP-1 mRNA expression in cultured
MC. Quiescent MC were treated with either PDGF-BB (25 ng/mL) or
80 mm Hg pressure for 10 minutes. The expressions of MCP-1 and
GAPDH mRNAs were analyzed by RT-PCR (A). Relative MCP-1
mRNA expression levels are expressed as the ratio against control
levels (without pressure) after normalization with GAPDH. Bars repre-
sent the mean  SD of three independent experiments (B). * P  0.05;
**P  0.01 vs. control (pressure ).
increase in MCP-1 mRNA expression. Both inhibitors
had no effect on the basal levels of MCP-1 mRNA (data
not shown). In contrast, wortmannin (500 nmol/L) failed
to inhibit pressure-induced increase in MCP-1 mRNA
expression. These results suggest that MAP kinase and
PKC pathways are involved in mediating the pressure-
Fig. 2. Effects of pressure on MCP-1 mRNA expression in cultured induced increase in MCP-1 mRNA expression (Fig. 6).mesangial cells (MC). After serum-deprivation of MC for 48 hours,
cells were exposed to 80 mm Hg pressure for indicated time intervals.
Pressure-induced p42/p44 MAP kinase activationEqual amounts (1 g) of total RNAs were reverse-transcribed and
amplified by PCR with specific PCR primers for MCP-1 and GAPDH. The next step focused on the effect of pressure on p42/After gel electrophoresis, PCR products stained by ethidium bromide
p44 MAP kinase activation and the resultant increase in(A) were quantified by scanning densitometry. Relative MCP-1 mRNA
expression levels are expressed as the ratio against 80 mm Hg pressure the expression of MCP-1. For this purpose, we examined
(0 min) after normalization with GAPDH. Data represent the mean  the role of p42/p44 MAP kinase in pressure-inducedSD of three independent experiments (B). *P  0.01; **P  0.001 vs.
increase in MCP-1 mRNA expression. The catalytic ac-0 min. MCP-1 mRNA expression also was analyzed by Northern blotting
after exposure of MC to 80 mm Hg pressure for indicated time inter- tivity of p42/44 MAP kinase was assayed by using a
vals (C). synthetic peptide as a specific substrate for MAP kinase.
Pressure at 80 mm Hg resulted in a rapid increase in
phosphatidylinositol (PI) 3-kinase (500 nmol/L wort- p42/p44 MAP kinase activity at one minute (3.2  0.2-
mannin) for 30 minutes before and during application fold). However, the increase was transient and decreased
of external pressure. As shown in Figure 6, PD98059 and to the basal level within five minutes. In contrast, the
level of p42/p44 MAP kinase activity in nonpressurizedcalphostin C significantly abrogated pressure-induced
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Fig. 5. Effects of pressure intensity on MCP-1 mRNA expression in
Fig. 4. Effect of pressure on MCP-1 protein production by cultured cultured MC. After exposure of quiescent MC to 0 to 100 mm Hg
MC. After exposure of MC to a pressure of 80 mm Hg for 10 minutes, pressure for 10 minutes, the expressions of MCP-1 and GAPDH
the level of MCP-1 protein was analyzed by Western blotting at 0 to mRNAs were analyzed by RT-PCR (A). Relative MCP-1 mRNA ex-
12 hours. Cell extracts (40 g protein) were subjected to Western pression levels are expressed relative to control levels (without pressure)
blotting with anti-MCP-1 antibody (A). After exposure of MC to a after normalization with GAPDH. Data represent the mean  SD of
pressure of 80 mm Hg for 10 minutes, the level of MCP-1 protein in four independent experiments (B). *P  0.05 vs. 0 mm Hg.
the culture medium was analyzed by ELISA at 0 to 24 hours. Values
represent mean  SD (N 	 3). *P  0.05 vs. control (pressure ).
Production of MCP-1 protein by control MC was 45 pg/mL (B).
lates MEK activity, which is immediately upstream of
MC remained unchanged for up to 10 minutes (Fig. 7A). p42/p44 MAP kinase. First, the effects of transfected
To further confirm the activation of p42/p44 MAP kinase MEK1 constructs on downstream p42/p44 MAP kinase
by pressure, we examined the phosphorylation levels of activities were assayed by Western blotting for phospho-
p42/p44 MAP kinase using anti-phospho p42/p44 MAP p42/p44 MAP kinase (Fig. 8A). Constitutively activated
kinase antibody. Similar to the results obtained in the MEK1 markedly increased the phosphorylation of p42/
kinase assay, p42/p44 MAP kinase phosphorylation lev- p44 MAP kinase without pressure. Wild-type MEK1 also
els also significantly increased by pressure loading com- activated MAP kinase; however, the activation level was
pared with the levels of nonpressurized MC. Treatment
less than that of constitutively activated MEK1. We also
of MC with PD98059 (25 mol/L) abrogated the pres-
confirmed similar expression levels of transfected MEK1sure-induced p42/p44 MAP kinase activation (Fig. 7 B,
constructs by Western blotting for HA (Fig. 8B). Consti-C), suggesting MEK-dependent activation of p42/p44
tutively activated MEK1 was of a smaller molecularMAP kinase.
weight due to the truncation, as described previously
Effects of wild-type and constitutively activated [32]. Interestingly, constitutively activated MEK1 in-
MEK1 on MCP-1 mRNA expression creased MCP-1 mRNA expression up to 13.7  7.5-fold
even without pressure loading (Fig. 9). These resultsTo investigate the role of p42/p44 MAP kinase activa-
indicate that activation of the MEK/MAP kinase path-tion in pressure-induced MCP-1 mRNA expression, we
used a transient transfection assay that specifically modu- way plays an important role in MCP-1 expression.
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Fig. 6. Effects of inhibitors of MEK, PKC, and phosphatidylinositol
3-kinase on pressure-induced MCP-1 mRNA expression in cultured
MC. MCs were treated without or with either PD 98059 (25 mol/L),
calphostin C (1 mol/L), or wortmannin (500 nmol/L) for 30 minutes
before and during 80 mm Hg pressure-loading for 10 minutes. The
expressions of MCP-1 and GAPDH mRNAs were analyzed by RT-PCR
(A). Relative MCP-1 mRNA expression levels are expressed relative to
control levels (with pressure) after normalization with GAPDH. Data
represent the mean  SD of three independent experiments (B). †P 
0.001 vs. control (pressure 
).
Fig. 7. Effects of pressure on ERK/MAP kinase activation in cultured
MC. (A) Effects of pressure on MAP kinase activity. After exposureDISCUSSION
of quiescent MC to 80 mm Hg pressure for indicated time intervals,
the catalytic activity of p42/44 MAP kinase was analyzed using a specificThe present study demonstrates, to our knowledge for
MAP kinase substrate as described in the Methods section. Symbolsthe first time, that externally applied pressure per se
are: () pressure apparent; () control. Values represent mean  SD
can induce MCP-1 mRNA expression in MC, and that (N 	 4). *P  0.05; **P  0.01; †P  0.001 vs. the respective control
group. (B and C) Effects of pressure on p42/p44 MAP kinase phosphory-MCP-1 production is pressure dependent and accompa-
lation. MC were treated without or with PD 98059 (25 mol/L) for 30nied by a rapid and transient activation of p42/p44 MAP
minutes before and during application of 80 mm Hg pressure for one
kinase. Pressure-induced MCP-1 expression was sup- minute. Cell extracts (40 g protein) were subjected to Western blotting
pressed by pretreatment of cells with a MEK inhibitor. with either anti-phospho p44/42 MAP kinase antibody or anti-MAP
kinase antibody (B). Relative p42/p44 MAP kinase phosphorylationWe also demonstrated that the constitutive-active form
levels were determined from Western blotting by densitometric analysisof MEK1 effectively increased MCP-1 expression with- and expressed relative to control levels (without pressure) (C). Values
out pressure loading. These results strongly indicate that represent mean  SD (N 	 3). †P  0.001 vs. pressure 
.
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Fig. 8. Effects of wild-type and constitutively activated MEK1 on ERK/
MAP kinase activation in cultured MC. (A) Effects of MEK1 constructs
on p42/p44 MAP kinase phosphorylation. MC were transfected without
or with either wild-type or constitutively activated HA-MEK1 together
with a puromycin-resistant plasmid. After selection of cells expressing
transfected plasmids in culture media containing puromycin (1 g/mL),
cells were serum-starved for 24 hours and exposed to 80 mm Hg pressure
for 10 minutes. Cell extracts (20 g protein) were subjected to Western
blotting with either anti-phospho p44/42 MAP kinase antibody (upper
panel) or anti-MAP kinase antibody (lower panel). (B) Expression of
transfected HA-MEK1 in MC. After transfection and selection of cells
expressing each MEK1 construct as described above, cell extracts (20
g protein) were subjected to Western blotting with anti-hemagglutinin
(HA) antibody.
Fig. 9. Effects of wild-type and constitutively activated MEK1 on
MCP-1 mRNA expression in cultured MCs. After transfection and
selection of MC expressing each MEK1 construct as described in the
Methods section, cells were serum-starved for 24 hours and total mRNApressure induces MCP-1 expression in MC through acti- was extracted from each cell without pressure-loading. Expressions of
vation of p42/p44 MAP kinase. MCP-1 and GAPDH mRNAs were analyzed by RT-PCR (A). Relative
MCP-1 mRNA expression levels are expressed relative to control levelsMonocyte chemoattractant protein-1 mRNA expres-
(without pressure) after normalization with GAPDH. Data representsion was observed within 5 minutes of application of the mean  SD of three independent experiments (B). *P  0.05 vs.
external pressure, reaching a peak level at 10 minutes, control (pressure ).
but returned to the control levels by 30 minutes. These
results indicate that MCP-1 expression induced by exter-
nally applied pressure was rapid and of a transient na-
induction of MCP-1 mRNA expression was dependentture. Our results are different from previous reports
on a critical level of externally applied pressure. Ourshowing that the induction of MCP-1 mRNA by other
results that MCP-1 expression levels at high pressurestimuli such as inflammatory cytokines and glucose oc-
(100 mm Hg) were less than those at 80 mm Hg indicatecurs after a few hours and lasts for more than several
that 80 mm Hg is the most effective physical pressurehours [9, 22, 24, 36]. The unique feature of pressure-
level for MCP-1 induction. These findings are consistentinduced MCP-1 expression might be due to differences
with those of our previous study demonstrating maximalin applied stimuli, employed signaling cascades, and cell
increases in DNA synthesis and MC proliferation in-types used. Furthermore, using Western blotting and
duced by external pressure of 80 mm Hg [6]. In pathologi-ELISA, we also confirmed that MCP-1 protein produc-
cal conditions in vivo, MC are persistently subjected totion within MC followed the secretion of its protein into
high pressure [2]. Although it remains to be clarifiedthe culture medium after pressure load (Fig. 4). The
whether the rapid induction of MCP-1 observed in ourdifference in the time course of MCP-1 mRNA and pro-
study plays a pathogenic role in vivo, our previous andtein levels might be due to differences in degradation
these findings that application of pressure to MC resultedrates; MCP-1 mRNA degrades rapidly, whereas its pro-
in a pressure level-dependent (80 mm Hg) inductiontein is relatively stable. Our results suggest that elevated
of MCP-1 expression as well as MC growth through thepressure, similar to inflammatory cytokines [9, 24, 36],
can directly induce mesangial MCP-1 expression. Also, induction of PDGF [6] strongly suggest that glomerular
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hypertension is likely to play important roles in the pro- MCP-1 expression is mediated, at least partly, by a rapid
gression of glomerular diseases. activation of p42/p44 MAP kinase pathway through tyro-
Several signaling pathways such as p42/p44 MAP ki- sine kinase.
nase, PKC, activator protein-1 (AP-1), and nuclear fac- Using the selective PKC inhibitor calphostin C, pres-
tor-B (NF-B) are involved in the regulation of MCP-1 sure-induced MCP-1 mRNA expression was abolished
expression [22–25, 37–44]. The present study design used by calphostin C as well as PD98059, suggesting the
inhibitors of MEK, PD98059, and that of PKC, calphos- involvement of PKC-dependent pathway in pressure-
tin C, to examine the likely intracellular mechanism that induced MCP-1 expression. However, pretreatment of
mediates the pressure-induced MCP-1 expression. Our MC with calphostin C failed to inhibit pressure-induced
results showed that PD98059 and calphostin C signifi- increase in p42/p44 MAP kinase phosphorylation levels
cantly inhibited pressure-induced MCP-1 mRNA expres- (data not shown). These results suggest that PKC is not
sion, whereas PI 3-kinase inhibitor, wortmannin, had located upstream of p42/44 MAP kinase and that the
no inhibitory effects. These results suggest that p42/p44 PKC pathway modifies pressure-induced MCP-1 expres-
MAP kinase and PKC pathways—but not that of PI 3-kin- sion via a pathway independent of p42/p44 MAP kinase
ase—are likely to be involved in the pressure-induced or below the level of MAP kinase in MCs, as suggested
MCP-1 expression in MCs. The involvement of p42/p44 previously [46]. Thus, PKC as well as p42/p44 MAP ki-
MAP kinase in this process was further supported by nase may play a major role in the pressure-induced
our findings that stimulation by PDGF-B, which is known MCP-1 expression. Our results are supported by those
to induce a rapid activation of MAP kinase (within 5 of earlier studies, which showed enhanced MCP-1 ex-
min) [16], significantly increased the levels of MCP-1 pression by other mechanical forces such as strain and
mRNA (2-fold compared with the level seen during shear stress through activation of PKC in human and
application of external pressure), as described previously bovine endothelial cells [43, 47].
[9, 24, 36]. Our results also showed that externally ap- Previous studies have shown that the genes encoding
plied pressure rapidly increased the catalytic activity of MCP-1 as well as PDGF in bovine aortic endothelial
p42/p44 MAP kinase with the peak level noted at one cells contain the shear-stress responsive element (SSRE)
minute (3-fold). Furthermore, using Western blotting, that responds to shear stress [47]. Furthermore, various
pressure rapidly increased p42/p44 MAP kinase phos- ion channels such as a stretch-activated ion channels
phorylation levels, and those levels were significantly and/or a mechanosensitive ion channel also are thought
inhibited by MEK inhibitor PD98059, findings that are to be involved in the transduction signals from mechani-
similar to those reported by Kawata et al [26]. Our results cal forces to cell membrane in some tissues including
are consistent with the previous findings reported by
MC [48, 49]. However, to our knowledge, there are no
Chien, Li and Shyy [37], which showed that PD98059, a
studies that have previously demonstrated the presenceMAP kinase inhibitor, abrogated angiotensin II-induced
of gene elements related to pressure such as SSRE orMCP-1 gene expression in endothelial cells. However,
pressure-related ion channels in MCs. At present, it isrecent studies also have shown the importance of p38
not clear how the cell senses increased external pressure.MAP kinase in cytokine-stimulated MCP-1 expression
Previously we have shown that external pressure in-in several cell types, including human MC [45]. Although
creased PDGF-B mRNA levels at three hours after ap-the reason for the discrepancy in MAP kinases signaling
plication, with a peak level occurring at six hours [6]. Inis not clear at present, it may reflect species differences
this respect, we cannot exclude the possible involvementor differences in the applied stimulus.
of cytokines such as PDGF in pressure-induced events.To confirm further the involvement of 42/p44 MAP
However, based on our previous [6] and present resultskinase in the pressure-induced MCP-1 expression, either
of apparent time lag between the expression of PDGF-Bwild-type or constitutively active MEK1 were transfected
and that of MCP-1, it is unlikely that PDGF-B inducesinto MC. Interestingly, the constitutively activated form
the early (10 min) enhanced expression of MCP-1 dem-of MEK1 effectively induced MCP-1 expression even
onstrated in the present study. Further studies are re-without externally applied pressure, suggesting that acti-
quired to identify the mechanisms involved in the per-vation of p42/p44 MAP kinase itself can induce MCP-1
ception of externally applied pressure stimulus.gene expression. These results strongly indicate the
In conclusion, the present study demonstrates thatinvolvement of the p42/p44 MAP kinase signal pathway
pressure stimuli per se produced a rapid and transientin pressure-induced MCP-1 expression. This study also
induction of MCP-1 expression in MC, through the acti-found that pressure-induced MCP-1 expression was in-
vation of p42/p44 MAP kinase pathway. Our resultshibited by genistein, a tyrosine kinase inhibitor (data not
point to the importance of lowering blood pressure inshown), which may support our earlier results indicating
glomerular hypertension to modulate mesangial MCP-1that pressure promoted a rapid increase in tyrosine ki-
nase [6]. Thus, our results suggest that pressure-induced expression.
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